GACM
CYTK icon

Green Arrow Capital Management’s Cytokinetics CYTK Stock Holding History

Green Arrow Capital Management’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-100,000
Closed -$757K – 266
2013
Q3 		$757K Sell
100,000
-200,000
-67% -$2.15M 0.06% 229
2013
Q2 		$3.47M Buy
+300,000
New +$2.36M 0.28% 114

Other funds holding CYTK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
IIM
Ironwood Investment Management Boston, Massachusetts $240M AUM 45.82% 1-Year Est. Return

Green Arrow Capital Management's CYTK Position: Q4 2013 in Review

Green Arrow Capital Management sold out of Cytokinetics (CYTK) in Q4 2013, closing a stake of 100,000 shares — an estimated $757K sold.

Green Arrow Capital Management first reported a position in CYTK in Q2 2013 and held it in 2 quarters. The position peaked at $3.47M in Q2 2013. 95 funds tracked by Wall St. Rank hold CYTK as of Q4 2013.

  • Green Arrow Capital Management reported no remaining Cytokinetics position as of Q4 2013 after selling out during the quarter.
  • Green Arrow Capital Management sold 100,000 Cytokinetics shares in Q4 2013, an estimated $757K.
  • Green Arrow Capital Management first reported a position in Cytokinetics in Q2 2013 and held it in 2 quarters.
  • Green Arrow Capital Management's Cytokinetics position peaked at $3.47M in Q2 2013.
  • 95 funds tracked by Wall St. Rank held Cytokinetics as of Q4 2013.

Based on Green Arrow Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.